Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Summary

This is a study to obtain clinical experience of 323U66 SR for elderly patients with depression in repeat-dose of 323U66 SR up to 300mg/day, and to conduct exploratory investigation on safety, efficacy and pharmacokinetics profile in elderly patients with depression.

Timeline

Start

2006-05

Primary completion

2007-11

Completion

2007-11

Drugs

Indications